-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price dropped 1.5% on Wednesday . The stock traded as low as $6.23 and last traded at $6.40. Approximately 914,451 shares were traded during trading, a decline of 73% from the average daily volume of 3,376,665 shares. The stock had previously closed at $6.50.
Mind Medicine (MindMed) Price Performance
The firm has a 50 day moving average of $7.44 and a 200-day moving average of $6.94.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- How to Calculate Inflation Rate
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Transportation Stocks Investing
- How Do Stock Buybacks Affect Shareholders?
- Insider Buying Explained: What Investors Need to Know
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
